atai Life Sciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/16/2026
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Oil slips as Saudi Arabia offers more crude via Oman
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Exclusive-SK Hynix in talks with Intel about deal to make memory chips in US for the first time, sources say
- Trade the FOMC: How stocks tend to perform on Fed hike days
- U.S. Commerce Department to sell up to 9.9M GlobalFoundries shares
- Generac strikes $8B supply deal with Amazon for data center power
- AI chip sell-off overblown: Zero GPU slowdown after Anthropic essay, analyst says
- Wall Street ends lower as oil spikes and the benchmark Treasury yield breaches 5%
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
atai Life Sciences N.V (ATAI) PT Lowered to $5 at Jefferies
August 13, 2024 4:04 PM EDTJefferies analyst Andrew Tsai lowered the price target on atai Life Sciences N.V (NASDAQ: ATAI) to $5.00 (from $6.00) while maintaining a Buy rating.
The analyst comments "ATAI's pipeline of psychedelics (and non-psychedelics) has pot'l to safely, profoundly, and durably treat tough $1B+... More
